High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer.
Zagouri F, Bago-Horvath Z, Rössler F, Brandstetter A, Bartsch R, Papadimitriou CA, Dimitrakakis C, Tsigginou A, Papaspyrou I, Giannos A, Dimopoulos MA, Filipits M.
Zagouri F, et al. Among authors: rossler f.
Br J Cancer. 2013 Mar 19;108(5):1100-5. doi: 10.1038/bjc.2013.31. Epub 2013 Feb 19.
Br J Cancer. 2013.
PMID: 23422757
Free PMC article.